|
|
Clinical observation of combined therapy of whole brain radiotherapy and Elemene Injection in the treatment of multiple brain metastases |
HU Daoqing1 LI Xiaodong2 |
1.Department of Oncology, BenQ Medical Center the Affiliated BenQ Hospital of Nanjing Medical University, Jiangsu Province, Nanjing 210019, China;
2.Department of Integrated TCM & Western Medicine, BenQ Medical Center the Affiliated BenQ Hospital of Nanjing Medical University, Jiangsu Province, Nanjing 210019, China |
|
|
Abstract Objective To explore the efficacy and side effects of Elemene Injection combined with whole brain radiotherapy in the treatment of multiple brain metastases. Methods A total of 56 patients with brain metastases treated by whole brain radiotherapy in BenQ Medical Center from April 2014 to April 2017 were collected. The changes of symptoms during hospitalization and the data of brain MRI after radiotherapy were collected. According to whether elemene was used or not, the patients were divided into elemene group and radiotherapy group. The changes of tumor size, symptom improvement and toxicity were compared between the two groups. Results The objective response rate between the elemene group (47.37%) and radiotherapy group (44.44%) had no signficant difference (P > 0.05). Compared with radiotherapy group, elemene group was better in controlling the symptoms of dizziness and headache, vomiting and fatigue (P < 0.05), without increasing the control rate of neurological symptoms and the conditions of acute radiotoxicity. When it came to the long-term radiotherapy response (after 6 months of radiotherapy), the incidence rate of memory loss in the elemene group was 21.74%, which was significantly lower than 63.64% in the radiotherapy group (P < 0.05). Conclusion Whole brain radiotherapy combined with Elemene Injection can increase the effect of radiotherapy and the rate of symptom control. But it can not increase the objective remission rate. Compared with radiotherapy alone, it dosen't increase acute radiotoxicity and can reduce the late toxicity to some extent. Elemene in combination with whole brain radiotherapy may be used in patients with brain metastases who are not suitable for chemotherapy or who are resistant to chemotherapy.
|
|
|
|
|
[1] Soffietti R,Rud R,Mutani R. Management of brain metastases [J]. J Neurol,2002,249(10):1357-1369.
[2] Yamamoto M,Serizawa T,Shuto T,et al. Stereotactic radiosurgery for patients with multiple brain metastases(JLGK0901):a multi-institutional prospective observational study [J]. Lancet Oncol,2014,15(4):387-395.
[3] 谈丽彩,何佳,孙增峰,等.多发脑转移瘤手术治疗临床病理回顾性分析[J].中华肿瘤防治杂志,2015,22(12):946-950.
[4] Cortes J,Rodriguez J,Aramendia JM,et al. Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer [J]. Oncology,2003,64(1):28-35.
[5] Kondziolka D,Patel A,Lunsford LD,et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases [J]. Int J Radiat Oncol Biol Phys,1999,45(2):427-434.
[6] 丁婕,戴旭,孟宪运,等.实体瘤疗效评价标准的研究进展[J].中国肿瘤临床与康复,2015,22(9):1150-1152.
[7] 李丛煌,花宝金,林洪生,等.中医治疗恶性肿瘤疗效评价研究的现状及思考[J].北京中医药,2010,29(3):187-190.
[8] 刘敬聘,秦坤明,王仁生,等.肺癌脑转移病灶患者伽马刀放射治疗及全脑放射治疗的疗效[J].中国医药导刊,2015,17(10):978-980.
[9] Jiang S,Ling C,Li W,et al. Molecular Mechanisms of Anti-cancer Activities of β-elemene:Targeting Hallmarks of Cancer [J]. Anticancer Agents Med Chem,2016,16(11):1426-1434.
[10] 彭彤,郭纪全,王其友,等.β-榄香烯体内外对人肺癌细胞株的作用及其机制[J].中国实验方剂学杂志,2015, 21(9):160-164.
[11] 李茹茹,史恒军,任秦有,等.β-榄香烯抑制HepG2细胞侵袭及转移的作用机制[J].现代肿瘤医学,2016,24(12):1870-1875.
[12] 沈洪,倪菲菲.β-榄香烯抗肿瘤免疫效应的研究进展[J].分子诊断与治疗杂志,2014,6(1):57-61.
[13] 郭建忠,魏尧,谷如雷,等.β-榄香烯诱导血管内皮细胞凋亡的研究[J].中国药物与临床,2016,16(8):1127-1129.
[14] 姚成才,涂远荣,姜杰,等.榄香烯乳诱导线粒体凋亡途径逆转肺癌A549/DDP细胞株耐药[J].现代肿瘤医学,2014,22(6):1276-1281.
[15] 王堃,苏成业.β-榄香烯在大鼠体内的药代动力学及体内过程[J].药学学报,2000,36(10):725-728.
[16] Li LJ,Zhong LF,Jiang LP,et al. β‐Elemene Radiosensitizes Lung Cancer A549 Cells by Enhancing DNA Damage and Inhibiting DNA Repair [J]. Phytother Res,2011,25(7):1095-1097.
[17] 佟恩娟.榄香烯对乏氧肺癌细胞的放射增敏作用与mTOR及HIF-1α/Survivin通路的相关性研究[D].大连:大连医科大学,2013.
[18] Zheng S,Yang H,Zhang S,et al. Initial study on naturally occurring products from traditional Chinese herbs and vegetables for chemoprevention [J]. J Cell Biochem Suppl,1997,27:106-112.
[19] 吴敏,王秦英.榄香烯乳治疗肺癌脑转移的临床研究[J].医学论坛杂志,2006,27(9):80-81.
[20] 池志恒,虞舜,温雯婷.榄香烯联合放疗干预肺癌脑转移系统评价[J].中国中医药信息杂志,2017,24(11):96-100.
[21] 苏进,钱莹,史克志,等.贝伐珠单抗治疗难治性瘤周脑水肿的近期疗效观察[J].中国肿瘤临床,2016,43(23):1045-1048.
[22] 周东晓,郭俊杰,谢颖,等.放射性脑损伤的血管损伤机制及贝伐珠单抗临床应用的研究进展[J].国际神经病学神经外科学杂志,2017,44(2):226-229.
[23] 胡晓,张欣,何佳倬,等.全脑放疗联合替莫唑胺治疗实体瘤脑转移的系统评价[J].现代预防医学,2014,41(10):1913-1918,封3.
[24] Robinet G,Thomas P,Breton JL,et al. Results of a phase Ⅲ study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer:Groupe Francais de Pneumo-Cancerologie(GFPC)Protocol 9 [J]. Ann Oncol,2001,12(1):59-67. |
|
|
|